José M González-Navajas Selected Research

Nitric Oxide (Nitrogen Monoxide)

3/2008

Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José M González-Navajas Research Topics

Disease

20	Fibrosis (Cirrhosis) 01/2020 - 09/2006
8	Inflammation (Inflammations) 10/2019 - 02/2014
6	Peritonitis 01/2020 - 07/2007
5	Melanoma (Melanoma, Malignant) 02/2022 - 01/2015
5	Ascites 10/2019 - 09/2006
5	Crohn Disease (Crohn's Disease) 01/2019 - 02/2014
4	Bacterial Infections (Bacterial Infection) 01/2018 - 07/2007
3	Liver Diseases (Liver Disease) 06/2019 - 01/2015
3	Infections 10/2014 - 05/2007
2	Hepatic Encephalopathy 10/2019 - 01/2017
2	Necrosis 02/2014 - 01/2008
1	Neoplasms (Cancer) 01/2021
1	Endotoxemia 10/2019
1	End Stage Liver Disease 10/2019
1	Portal Hypertension 10/2019
1	Pancreatitis 05/2017
1	Disease Progression 05/2017
1	Sudden Infant Death (SID) 12/2016
1	Critical Illness (Critically Ill) 10/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2016
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 09/2014
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2014
1	Virus Diseases (Viral Diseases) 01/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2012
1	Colitis 02/2010

Drug/Important Bio-Agent (IBA)

10	Bacterial DNAIBA 01/2019 - 09/2006
8	Norfloxacin FDA Link 01/2020 - 09/2006
6	InflammasomesIBA 02/2022 - 01/2012
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 09/2006
3	Interleukin-10 (Interleukin 10)IBA 01/2019 - 02/2010
3	Bacterial AntigensIBA 12/2018 - 07/2014
3	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2018 - 10/2014
3	CytokinesIBA 11/2017 - 03/2008
3	Phenobarbital (Luminal)FDA Link 10/2016 - 10/2014
3	EndotoxinsIBA 10/2014 - 07/2007
2	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 01/2019
2	Interleukin-18 (Interleukin 18)IBA 05/2017 - 01/2015
2	AntigensIBA 01/2017 - 02/2016
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 09/2014
2	Biological ProductsIBA 07/2015 - 09/2006
2	Interleukin-6 (Interleukin 6)IBA 01/2008 - 09/2006
1	Butyrates (Butyrate)IBA 10/2019
1	Butyric Acid (Butanoic Acid)IBA 10/2019
1	Adalimumab (Humira)FDA Link 01/2019
1	Infliximab (Remicade)FDA Link 01/2019
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	AlbuminsIBA 01/2019
1	Volatile Fatty AcidsIBA 12/2018
1	Rifaximin (L 105)FDA Link 01/2018
1	Messenger RNA (mRNA)IBA 05/2017
1	Lactulose (Duphalac)FDA LinkGeneric 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016
1	Proton Pump InhibitorsIBA 01/2015
1	Pattern Recognition ReceptorsIBA 09/2014
1	Antimicrobial PeptidesIBA 09/2014
1	NucleotidesIBA 02/2014
1	LigandsIBA 01/2012
1	InterferonsIBA 01/2012
1	AS 8IBA 02/2010
1	Indicators and Reagents (Reagents)IBA 12/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2008
1	Complement System Proteins (Complement)IBA 07/2007
1	Proteins (Proteins, Gene)FDA Link 07/2007
1	Monoclonal AntibodiesIBA 05/2007
1	Immunoglobulins (Immunoglobulin)IBA 05/2007

Therapy/Procedure

2	Ligation 01/2020 - 10/2014
2	Oral Administration 06/2019 - 01/2018
2	Therapeutics 07/2015 - 02/2014
1	Immunotherapy 01/2021
1	Immunomodulation 01/2020
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 10/2019
1	Liver Transplantation 01/2019
1	Biological Therapy 02/2014
1	Laparotomy 05/2007